When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company.
Mr. Brodersen has 30 years of animal health sales and marketing leadership experience EAST BRUNSWICK, N.J.–(BUSINESS WIRE)– Cronus Pharma LLC, a fully integrated research & development, manufacturing and marketing animal health pharmaceutical company, announced Mr. Todd Brodersen has joined as Senior Director of Sales & Marketing. Mr. Brodersen has thirty years of animal health industry […]
September 21, 2020 – Cronus Pharma believes US FDA approval for its new manufacturing site will be a major milestone on its way to becoming a veterinary generic pharmaceuticals leader. The East Brunswick, New Jersey-headquartered business started life bringing crossover drugs from the humanpharmaceuticals market into animal health. Now it has become a fully integrated […]
East Brunswick, N.J., December 7, 2016 (BUSINESSWIRE) – (Cronus Pharma LLC, an emerging animal health company focused on the development and marketing of prescription pharmaceuticals to improve the lives and health of companion animals, announced the commercial launch of Clindamycin Hydrochloride Oral Liquid (25mg/20mL) in a 20mL bottle, a generic version of Antirobe Aquadrops®. Clindamycin […]
2 Tower Center Blvd., Suite 1101A
East Brunswick, NJ 08816-1100
Phone: 1.844.227.6687
contact@cronuspharmausa.com